Home/Filings/4/0001235802-12-000026
4//SEC Filing

Snabes Michael C 4

Accession 0001235802-12-000026

CIK 0001023024other

Filed

Jan 26, 7:00 PM ET

Accepted

Jan 27, 4:37 PM ET

Size

5.9 KB

Accession

0001235802-12-000026

Insider Transaction Report

Form 4
Period: 2012-01-25
Snabes Michael C
Sr. VP of Clinical Affairs
Transactions
  • Award

    Employee Stock Option (right to buy)

    2012-01-25+165,000165,000 total
    Exercise: $0.68Exp: 2022-01-24Common Stock (165,000 underlying)
Holdings
  • Common Stock

    0
Footnotes (1)
  • [F1]This option vests with respect to 41,250 shares on each of January 25, 2013, January 25, 2014, January 25, 2015 and January 25, 2016.

Issuer

BIOSANTE PHARMACEUTICALS INC

CIK 0001023024

Entity typeother

Related Parties

1
  • filerCIK 0001500112

Filing Metadata

Form type
4
Filed
Jan 26, 7:00 PM ET
Accepted
Jan 27, 4:37 PM ET
Size
5.9 KB